March 2, 2018 – Biogen and AbbVie announce plans to withdraw Zinbryta globally following reports of inflammatory encephalitis and meningoencephalitis associated with the drug.
March 2, 2018 – Biogen and AbbVie announce plans to withdraw Zinbryta globally following reports of inflammatory encephalitis and meningoencephalitis associated with the drug.